Kion Aminos, decoded: what the label actually delivers for GLP-1 muscle protection By Aali Qureshi, founder of Deadly Company · Published October 24, 2026 · Updated October 31, 2026 Short answer: Kion Aminos discloses its full label. Per serving, those amounts add up to roughly 5g of essential amino acids: 2g of leucine, below the […]

Do amino acids break a fast? The honest answer for GLP-1 users By Aali Qureshi, founder of Deadly Company · Published October 24, 2026 · Updated October 31, 2026 Short answer: Yes. By the strict definition (no calories, no protein, no nutrient signal), amino acids break a fast: leucine is a nutrient signal that switches […]

Do EAAs raise blood sugar? What the evidence actually shows By Aali Qureshi, founder of Deadly Company · Published October 24, 2026 · Updated October 31, 2026 Short answer: Essential amino acids are not sugar, and a plain EAA serving should not be expected to act like a sugary drink. But amino acids are not […]

Travelling on a GLP-1: portable protein that isn’t a shake By Aali Qureshi, founder of Deadly Company · Published October 24, 2026 · Updated October 31, 2026 Short answer: Travel deletes the infrastructure a GLP-1 routine depends on: ready-to-drink shakes hit carry-on liquid limits and need a fridge, bars melt and demand chewing through nausea, […]

Hair shedding on a GLP-1: what protein has to do with it, honestly By Aali Qureshi, founder of Deadly Company · Published October 24, 2026 · Updated October 31, 2026 Short answer: Shedding months into GLP-1 treatment is explained by the weight loss itself: rapid loss triggers telogen effluvium, pushing hairs into the shedding phase, […]

Bone density and GLP-1 weight loss: the protein and training connection By Aali Qureshi, founder of Deadly Company · Published October 24, 2026 · Updated October 31, 2026 Short answer: Weight loss from any cause tends to cost bone density: a lighter skeleton is loaded less, and bone remodels toward the load it carries. GLP-1 […]

Protein on a GLP-1 with type 2 diabetes: what to discuss with your clinician By Aali Qureshi, founder of Deadly Company · Published October 24, 2026 · Updated October 31, 2026 Short answer: With type 2 diabetes, the GLP-1 protein question has a layer the advice lacks: kidneys, glucose-lowering medications, and monitoring interact with intake […]

Bariatric surgery vs GLP-1 protein rules: what’s the same, what’s different By Aali Qureshi, founder of Deadly Company · Published October 24, 2026 · Updated October 31, 2026 Short answer: Bariatric programmes solved the can’t-eat problem first: capacity collapses, and protein is the first casualty, shared by both rulebooks. The maths differ. Bariatric guidance runs […]

Anabolic resistance: why muscle gets harder to feed as you lose weight and age By Aali Qureshi, founder of Deadly Company · Published October 24, 2026 · Updated October 31, 2026 Short answer: Anabolic resistance is why older, inactive, or losing muscle responds less to protein: the signal from a feeding comes back muted. Ageing, […]

Muscle protein synthesis, explained in plain English By Aali Qureshi, founder of Deadly Company · Published October 24, 2026 · Updated October 31, 2026 Short answer: Muscle protein synthesis (MPS) is how your body builds new muscle protein from amino acids; it runs opposite breakdown, and the balance between the two decides whether you gain, […]